Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Gerry B. Berg
Introduction
Gerry B. Berg is a notable inventor based in Oceanside, CA (US). She has made significant contributions to the field of oncology through her innovative research and development of therapeutic compositions. Her work focuses on enhancing anti-tumor immune responses, which is crucial in the fight against cancer.
Latest Patents
Gerry B. Berg holds a patent titled "Augmentation of oncology immunotherapies by pterostilbene containing compositions." This patent discloses compositions and methods that are useful for enhancing, improving, or eliciting anti-tumor immune responses. The pterostilbene containing composition is administered to cancer patients at sufficient concentrations and frequencies to induce de-repression of tumor-targeting immune responses. This composition enhances antibody-dependent cellular toxicity (ADCC) and augments the efficacy of antigen-specific immunotherapeutics, such as trastuzumab and other monoclonal antibody therapies that are beneficial for treating cancer.
Career Highlights
Gerry B. Berg is associated with Therapeutic Solutions International, Inc., where she continues to advance her research in oncology. Her work is pivotal in developing new therapies that can improve patient outcomes in cancer treatment.
Collaborations
Gerry collaborates with esteemed colleagues, including Timothy G. Dixon and Robert F. Graham, who contribute to her innovative projects and research initiatives.
Conclusion
Gerry B. Berg's contributions to oncology through her patented innovations demonstrate her commitment to improving cancer therapies. Her work not only enhances the understanding of immune responses but also paves the way for more effective treatments for cancer patients.